Cancer and the Combination Approach

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches

NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Jazz Pharmaceuticals

By Liz Henderson

Liz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses pioneering innovation in oncology and the importance of the manufacturing infrastructure to help achieve drug development goals.

Originally published by the Medicine Maker

Historically, innovation in the pharmaceutical industry has centered around the discovery of active pharmaceutical ingredients. A new, potentially life-saving treatment, however, can only make a difference if physicians can access a reliable supply. Drug shortages in oncology are not new. The global COVID-19 pandemic saw an increase in critical supply chain issues in the manufacture of drugs, which even further underscored the need for continued advancements in the manufacturing of oncology medicines.

Continue reading here

View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.

Contact Info:
Spokesperson: Jazz Pharmaceuticals
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals
Email: [email protected]

SOURCE: Jazz Pharmaceuticals

You May Also Be Interested In

• Silver, Gold Prices Retreat as Markets React to Warsh’s Jackson Hole Speech
• ALL WITHIN MY HANDS PARTNERS WITH CNH TO CELEBRATE LABOR DAY WITH AUCTION OF FINAL HETFIELD LIMITED EDITION CASE COMPACT TRACK LOADER
• Vobile Signs Strategic Cooperation and Commercial Agreements with UNN to Build AI Factories in Brunei Darussalam